Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2008-01-01
2008-01-01
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S015000, C435S069100, C435S069300, C435S325000, C435S364000, C435S320100, C536S023200, C536S023720
Reexamination Certificate
active
07314710
ABSTRACT:
The invention concerns the use of cells capable of carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome, such as prenylation of the NS5A protein, for replicating and, if required, the production of HCV or derivative viable mutants, in a suitable culture medium.
REFERENCES:
patent: 5571712 (1996-11-01), Haynes et al.
patent: 5998174 (1999-12-01), Glorioso et al.
patent: 6127116 (2000-10-01), Rice et al.
patent: 6153421 (2000-11-01), Yanagi et al.
patent: 6159939 (2000-12-01), Glenn
patent: 2004/0234506 (2004-11-01), Jin et al.
patent: WO94/25064 (1994-11-01), None
patent: WO96/24662 (1996-08-01), None
Bartenschlager et al., “Replication of the hepatitis C virus in cell culture,” Antiviral Research, vol. 60 No. 2, pp. 91-102 (Oct. 2003).
Bartenschlager, Ralf, “The hepatitis C replicon system; From basic research to clnical application,” Journal of Hepatology, vol. 43, No. 2, pp. 210-216 (Aug. 2005).
Bartenschlager, Ralf, “Hepatitis C virus replicons: potential role for drug development,” Nature Reviews, Drug Discovery, vol. 1 No. 11, pp. 911-916 (Nov. 2002).
Bonte et al., Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication, Archives of Virology, vol. 149 No. 7, pp. 1353-1371 (Jul. 2004).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,” Science, vol. 247 No. 4948, pp. 1306-1310 (Mar. 1990).
Frese et al., “Human MxA Protein Inhibits Tick-Borne Thogo Virus but Not Dhori Virus,” Journal of Virology, vol. 69 No. 6, pp. 3904-3909 (Jun. 1995).
Heller et al., “An in vitro model of hepatitis C virion production,” Proceedings of the National Academy of Sciences, USA, vol. 102 No. 7, pp. 2579-2583 (Feb. 2005).
Lohmann et al., “Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line,” Science, vol. 285 No. 5424, pp. 110-113 (Jul. 1999).
Pietschmann et al., “Persistent and transient replication of full-length hepatitis C virus genomes in cell culture,” Journal of Virology, vol. 76 No. 8, pp. 4008-4021 (Apr. 2002).
Valli M B et al.: Hepatitis C Virus Infection of a Vero Cell Clone Displaying Efficient Virus-Cell Binding Research in Virology, Elsevier, Paris, Fr., vol. 148, No. 2, Mar. 1997, pp. 181-186, XP000878532 ISSN: 0923-2516.
Germi R et al:“Hepatitis C virus adsorption step study on different cell lines.”, Travaux Scientifiques Des Chercheurs Du Service De Sante Des Armees, No. 20, pp. 55-56, XP001042364, ISSN: 0243-7473 1999.
Germi R et al.: “Les systemes de culture du virus de 1′hepatite C.”, Pathologie Biologie, vol. 49, No. 3, Apr. 2001. pp. 255-261, XP001042317, ISSN: 0369-8114.
Bartenschlager Ralf et al.: “Replication of hepatitis C virus.”, Journal of General Virology, vol. 81, No. 7, Jul. 2000, pp. 1631-1648, XP002186769 ISSN: 0022-1317.
Dubuisson Jean
Duverlie Gilles
Pillez André
Wychowski Czeslaw
Centre National de la Recherche Scientifique
Lucas Zachariah
Young & Thompson
LandOfFree
Method for replicating the hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for replicating the hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for replicating the hepatitis C virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807637